by Greg Kuehn | Mar 20, 2020 | Research News
Research will examine prevalent gut microbial markers present in colorectal cancer CARLSBAD, Calif., June 2, 2020 /PRNewswire/ — Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., announced today a research...
by Greg Kuehn | Oct 6, 2012 | Press Releases
Metabiomics will describe its approach for developing a sequencing-based, non-invasive screening test for colorectal cancer at the Colorado Capital Conference and OCTANe Medical Device & Investor Forum Potomac Falls, Virginia (October 5, 2012)...
by Greg Kuehn | Sep 21, 2012 | Press Releases
Metabiomics Selected to Present Molecular Diagnostic Innovations and Growth Strategy at Annual Mid-Atlantic BIO Conference Potomac Falls, Virginia (September 17, 2012) Metabiomics, a Northern-VA-based molecular diagnostics firm, was selected by the Mid-Atlantic Bio...
